Table 2. Part-Worth Utilities From Conjoint Scenariosa.
Attribute | Coefficient (95% CI) | P value |
---|---|---|
User | ||
Pharmaceutical company | −0.19 (−0.22 to −0.16) | <.001 |
Digital technology company | −0.23 (−0.26 to −0.20) | <.001 |
University hospital | [Reference] | NA |
Information type | ||
Places you visit via applications on your phone | 0.00 (−0.06 to 0.05) | .94 |
Places you visit via public cameras | −0.28 (−0.33 to −0.22) | <.001 |
Walking via applications on phone | 0.22 (0.17 to 0.28) | <.001 |
Internet searches via search engines | −0.11 (−0.17 to −0.06) | <.001 |
Purchases via online retail | 0.01 (−0.04 to 0.07) | .63 |
Genetic info via genetic testing companies | 0.06 (0.00 to 0.12) | .05 |
Communication via social media | −0.20 (−0.26 to −0.15) | <.001 |
Spending or finances via banks and credit cards | −0.56 (−0.62 to −0.50) | <.001 |
Health via EHR | [Reference] | NA |
Use | ||
Clinical care | −0.06 (−0.09 to −0.03) | <.001 |
Marketing | −0.16 (−0.19 to −0.13) | <.001 |
Research | [Reference] | NA |
Disease | ||
Diabetes | −0.05 (−0.08 to −0.01) | .008 |
Depression | −0.09 (−0.13 to −0.06) | <.001 |
COVID-19 | 0.05 (0.02 to 0.09) | .003 |
Cancer | [Reference] | NA |
Abbreviations: EHR, electronic health care record; NA, not applicable.
Part-worth utilities from linear generalized estimating equation model.